Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine
Combination treatment with 0.025% atropine and DIMS spectacle lenses is more effective in controlling axial elongation than 0.025% atropine with SV lenses. Although not significant, SER differences between groups were lower in group B. These findings support a potential additive effect of the two treatments.
Authors
- Rosario Gómez de Liaño (ORCID: https://orcid.org/0000-0001-6952-4521)
- Elena Hernandez-García (ORCID: https://orcid.org/0000-0002-2474-7294)
- Alicia Ruiz‐Pomeda (ORCID: https://orcid.org/0000-0002-8318-5914)
- Paula Talavero González
- Beatriz Martin‐García (ORCID: https://orcid.org/0000-0002-5238-315X)
- Rakhee Shah (ORCID: https://orcid.org/0000-0002-6134-0936)
- Noemí Güemes-Villahoz (ORCID: https://orcid.org/0000-0002-9289-1212)
- Paloma Porras-Ángel
- Rafael Bella‐Gala (ORCID: https://orcid.org/0000-0003-1469-718X)
- Nunila Gomez de Liaño (ORCID: https://orcid.org/0009-0008-8341-1599)
Institutions
- Universidad Complutense de Madrid (ES)
- St George's, University of London (GB)
- City, University of London (GB)
- Netherlands Institute for Sound and Vision (NL)
- Hospital Clínico San Carlos (ES)
Publication Details
- Journal
- British Journal of Ophthalmology
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1136/bjo-2024-326852
- Citations
- 7
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 9.48